Latest News

Overall survival results from ICON6 recurrent ovarian cancer trial

Making Trial Data Count Twitter Q&A

Upfront abiraterone improves survival for men with prostate cancer

Did you miss our #smallpopulations Twitter Q&A? Catch up here

How can we design trials in smaller populations? Join our Twitter Q&A